Home | My Account | Online Store | Contact & Demand | Press Room | About Us | FAQs
Home
Buy & Subscribe
Special Features
Products & Services
Online Store
Products by category
Products by publisher
Product lines
News Channels
Biotechnology
Therapeutic Areas
Business
RSS Feeds
Free RSS News
Get the latest news direct
to your desktop
feed image

Search in our News Channels

  

Search in our Online Store
Biomarkers
Filter     Order     Display # 
Date Item Title
12 Apr 2006 Inflammatory-Enzyme Shown to Predict Risk of Cardiovascular Events After Acute Coronary Syndromes
11 Apr 2006 Pharmaxis Completes Enrolment In Aridol CODP Trial
06 Apr 2006 Clinical Study Proves Prognostic Power of Epigenomics' Biomarker in Prostate Cancer
04 Apr 2006 Biosite and Oxford Genome Sciences Announce Collaboration in Colorectal Cancer
31 Mar 2006 National Institute of Radiological Sciences Develops DNA Chip-based Risk Prediction System for Side-effect Occurrence in Cancer Radiation Therapy
30 Mar 2006 Caprion Pharmaceuticals Announces New Biomarker Discovery Collaboration with Vertex Pharmaceuticals
30 Mar 2006 Ameripath Announces Advanced Testing For Myeloproliferative Disorders
30 Mar 2006 Nanogen Receives 510(k) Clearance for StatusFirst(TM) Congestive Heart Failure NT-proBNP Test
25 Mar 2006 NMP22(R) BladderChek(R) Test Detected 100% of Dangerous Tumors in Women at Risk for Bladder Cancer; Women Have a Disproportionately Higher Death Rate from Bladder Cancer than Men
24 Mar 2006 Ciphergen Presents Data on Novel Biomarkers to Aid in the Differential Diagnosis of a Pelvic Mass at the 37th Annual Meeting for the Society of Gynecologic Oncologists
23 Mar 2006 Chondrogene Reports On Blood-Based Prostate Cancer Diagnostic Test Development
20 Mar 2006 Lilly and Biosite to Collaborate on Clinical Trial Using Tailored Xigris Therapy
20 Mar 2006 Tm Bioscience Acquires Key Sepsis Biomarkers From Sirius Genomics
10 Mar 2006 Epigenomics Confirms Lead Marker for Prediction of Breast Cancer Relapse
09 Mar 2006 Digilab BioVisioN GmbH Closes Cooperation Agreement With Boehringer Ingelheim
01 Mar 2006 Bayer HealthCare licenses urinary trypsin inhibitor immunoassays to Signet Laboratories to further research inflammatory disease
27 Feb 2006 German Researchers Detail Efficacy of AMDL's DR-70 Cancer Test as Tumor Marker for Ovarian Carcinoma
23 Feb 2006 LabCorp® Exclusively Licenses Yale Technology For New Early Stage Ovarian Cancer Blood Test
23 Feb 2006 Chondrogene reports on blood-based colon cancer test development
18 Feb 2006 CytoCore Announces the Licensing of a New Bio-Marker That Identifies Uterine Pre-Cancerous and Cancer Cells
14 Feb 2006 Blood Test to Detect Alzheimer's a Step Closer; Second Study Confirms DiaGenic ASA's Breakthrough Test Method for Alzheimer's Disease
10 Feb 2006 Data Highlighting the Role of Molecular Diagnostics Presented at Major HIV/AIDS Meeting
09 Feb 2006 Genzyme Launches Key Test To Monitor Gleevec® Resistance
08 Feb 2006 Ciphergen Announces Pharmaceutical Biomarker Research
01 Feb 2006 GTx and Gen-Probe to Study the Ability of Research-Stage Diagnostic Test to Detect High Grade PIN
31 Jan 2006 DiaGenic ASA (NO) - RESULTS - ALZHEIMER'S DISEASE
27 Jan 2006 Genomic Health Plans to Meet With FDA in Response to Invitation
25 Jan 2006 Caprion Pharmaceuticals announced a research collaboration with Berlex
19 Jan 2006 Matritech's NMP22(R) BladderChek(R) Test Detects Bladder Cancers in Symptomatic Patients Missed by Traditional Laboratory Test; Military Veterans with Blood in Their Urine Reported to Have Twice the Incidence of Bladder Cancer as Other Individuals
 
<< Start < Prev 1 2 Next > End >>
Results 51 - 79 of 79

PipelineReview.com is powered by La Merie Business Intelligence La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Passatge Jordi Ferran, 20 | E-08028 Barcelona | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L

Competitor Analysis Series

Thrombopoiesis-Stimulating Agents (TPO)

Order Now

Brief Report Series

CD40 and CD40L (CD154) Agonists & Antagonists

Order Now

Subscribe La Merie Biologics